Par Drugs & Chemicals Ltd Share Price

Pharmaceuticals - Indian - Bulk DrugsNSE
₹125.79
+1.84+1.48% (1D)
As on 5 Oct 2026 at 23:21
As of 5 Oct 2026 at 23:21, Par Drugs & Chemicals Ltd is trading at ₹125.79, with a market cap of ₹154.78 crore. At a P/E of 10.68 and a dividend yield of 0.00%, it is a small-cap stock in the Pharmaceuticals sector.

PAR Price Chart

Market Cap
₹154.78 Cr
PE Ratio
10.68
ROCE
15.56%

Par Drugs & Chemicals Ltd Performance

Par Drugs & Chemicals Ltd Fundamentals

Market Cap₹154.78 Cr
ROE11.71%
P/E Ratio (TTM)10.68
EPS (TTM)₹11.78
P/B Ratio1.38
Dividend Yield0.00%
Industry P/E88.19
Book Value₹91.01
Debt to Equity0.00
Face Value₹10

Par Drugs & Chemicals Ltd Shareholding Pattern

Promoter73.4%
Foreign Institutions0%
Mutual Funds0%
Domestic Institutions0.1%
Public26.5%

Par Drugs & Chemicals Ltd Financial Statements

04080120₹96FY24+5.57%₹101FY25+2.66%₹104FY26

*All values are in INR Crore

Par Drugs & Chemicals Ltd Peer Comparison

StocksLTP(₹)Market Cap(Cr)52 Week Low-High(₹)
Sun Pharmaceutical Industries Ltd
₹1,782.00
-19.00(-1.05%)
4,27,561.51,583.7 - 2,046.9
Torrent Pharmaceuticals Ltd
₹4,755.15
-12.15(-0.25%)
1,80,870.6—
Cipla Ltd
₹1,334.00
-10.00(-0.74%)
1,07,769.9—
Dr Reddys Laboratories Ltd
₹1,208.00
1.80(+0.15%)
1,00,829.4—
Lupin Ltd
₹2,010.00
-21.20(-1.04%)
91,915.3—

About Par Drugs & Chemicals

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat on 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. The Company began in 1982 under the vision of the founder, Late Shri Vallabhbhai J. Savani. The Company discontinued its existing pharmaceutical and chemical operations and diversified into an entirely new vertical line of business. With shareholder approval, the Company is investing in real estate & construction, clean & renewable energy, and capital markets. At present, Company is engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx. 9,700 MTPA. Block 1- APIs, Block 2- Magnesium Hydroxide, Block 3- Fine Chemicals and Block 4- APIs/ Fine Chemicals. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals. The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited. The Company raised money from public through IPO by issuing 16,72,000 Equity Shares aggregating to Rs 8.53 Crore in May, 2019. In June, 2021, the Company started a set of new production line-up i.e. one new manufacturing block, which increases production capacity within the existing product portfolio i.e. same as per existing product portfolio and market. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx 9,700 MTPA. Block 1 - APls, Block 2 - Magnesium Hydroxide, Block 3 - Fine Chemicals and Block 4 - APls/ Fine Chemicals.

Parent Organisation—
Founded1999
Managing Director—
NSE SymbolPAR

Par Drugs & Chemicals Ltd Resistance and Support levels

R3128.84R2127.06R1125.97S1122.42S2121.33S3119.56125.79

Par Drugs & Chemicals Ltd Technicals

Current Price
₹125.79 ₹1.84 (+1.48%)
Bearish
6
Bullish
6
  • 20 Day2.8%
  • 50 Day4.6%
  • 100 Day13.8%
  • 200 Day17.5%

Par Drugs & Chemicals Ltd Latest News

View More
07 MAY 2026 | Thursday
Par Drugs & Chemicals to hold board meeting

2026

Board MeetingAnnounced
Board MeetingAnnounced
Board MeetingAnnounced
Board MeetingAnnounced

Frequently asked questions

The share price of Par Drugs & Chemicals Ltd is ₹125.79 as of 5 Oct 2026 at 23:21.

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now